In a report released today, Allan Franklin from Canaccord Genuity maintained a Buy rating on Experience Co Ltd (EXP – Research Report), with a ...

In a report released on January 23, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Next Science Ltd (NXSCF – Research Report), ...

We are witnessing a transformative era in energy investments “that looks and feels a lot like the communications revolution several decades ago,” said George Gianarikas, Canaccord Genuity ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In other recent news, Cibus Inc. has seen significant developments. Canaccord Genuity analysts revised their price target for Cibus, reducing it from $20.00 to $18.00, while maintaining a Buy rating.

In this newly developed executive team role, Dr. Levine will be responsible for ensuring that patient-centric strategies are embedded across the organization ... in the Canaccord Genuity 44th ...

At close: 24 January at 15:16:44 GMT-5 ...

An acquisition by a larger healthcare organization or private equity firm could provide Evolent with additional resources and scale to accelerate its growth strategies. A strategic buyer in the ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...